Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Pharma
GSK allows generic versions of cabotegravir for HIV treatment
GSK has expanded its agreement with the Medicines Patent Pool, allowing generic production of cabotegravir as an HIV treatment in poorer nations.
Kevin Dunleavy
Jul 15, 2025 2:16pm
As GSK eyes Blenrep's US return, FDA flags eye safety concerns
Jul 15, 2025 10:52am
Delaware court rules against expert testimony in Zantac cases
Jul 11, 2025 12:10pm
Respiratory royalty rally around rural COPD education drive
Jul 9, 2025 8:05am
RemeGen, Harbour, Datroway—Fierce Pharma Asia
Jun 27, 2025 8:37am
Uptake of Gilead's Yeztugo will be swift, analyst says
Jun 25, 2025 2:51pm